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Macrophages constitute a powerful line of defense against H. pylori. The final disease
outcome is highly dependent on the bacterial ability to modulate the effector functions
of activated macrophages. Here, we report that H. pylori secreted protein HP1286 is a
novel regulator of macrophage responses. Differential expression and release of HP1286
homologues were observed among H. pylori strains. Recombinant purified HP1286
(rHP1286) had the ability to bind to primary human monocyte-derived macrophages
(MDM) and macrophage cell lines. Exposure to rHP1286 induced apoptosis in
macrophages in a dose- and time-dependent manner. Although interaction of rHP1286
was observed for several other cell types, such as human monocytes, differentiated
neutrophil-like HL60 cells, and the T lymphocyte Jurkat cell line, rHP1286 failed to
induce apoptosis under similar conditions, indicating a macrophage-specific effect
of the protein. A mutant strain of H. pylori lacking HP1286 protein expression was
significantly impaired in its ability to induce apoptosis in macrophages. Significantly higher
caspase 3 activity was detected in rHP1286-challenged macrophages. Furthermore,
rHP1286-induced macrophages apoptosis was not inhibited in the presence of
neutralizing antibodies against TNF. These observations indicate that rHP1286 induced
a caspase-dependent and TNF-independent macrophage apoptosis. Pre-treatment of
macrophages with U0126, an inhibitor of the ERK MAPK signaling pathway significantly
reduced rHP1286-induced apoptosis. Furthermore, nuclear translocation of ERK and
phosphorylation of c-Fos was detected in rHP1286-treated macrophages. These results
provide functional insight into the potential role of HP1286 during H. pylori infection.
Considering the ability of HP1286 to induce macrophage apoptosis, the protein could
possibly help in the bacterial escape from the activated macrophages and persistence
in the stomach.
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INTRODUCTION
The Gram-negative bacterium Helicobacter pylori is known to
selectively colonize the human gastric mucosa for over 50,000
years. Currently, more than half of the world’s population is
colonized by H. pylori. Even though most of the infections
are asymptomatic, long-term colonization can lead to chronic
gastritis and the development of ulcers, adenocarcinoma
and mucosa-associated lymphoid tissue (MALT) lymphoma
(Wroblewski et al., 2010). In spite of the generation of strong
immune responses against the bacterium, the host fails to
eradicate the infection in the majority of cases. This is partly due
to the fact that the bacterium has developed several strategies
to modulate the effector functions of immune cells for its own
survival and benefit. Macrophages play an important role in the
host defense against H. pylori through several strategies, such as
phagocytosis, production of various cytokines/chemokines, and
microbicidal compounds such as ROS and NO (Wilson et al.,
1996; Gobert et al., 2002a,b). However, H. pylori is known to
block or regulate these macrophage strategies, which results in
inefficient bacterial killing. Induction of programmed cell death
or apoptosis in macrophages is a well-known bacterial strategy
that helps in the colonization and persistence of the bacterium.
It has been reported previously that H. pylori or bacterium-
derived products induce apoptosis in macrophages, which occurs
via polyamine-dependent mechanisms and signaling via ERK-
MAPK and the Src family of tyrosine kinases (Allen et al., 2000;
Zheng and Jones, 2003; Chaturvedi et al., 2004; Asim et al., 2010;
Pathak et al., 2013).
Despite the small size of the H. pylori genome, a large
fraction, presumably from 30 to 40%, is annotated as hypothetical
proteins with unknown function (Zanotti and Cendron, 2014).
Among this group, many are secreted by the bacterium. Based on
various studies, the H. pylori secretome appears to be composed
of approximately 160 proteins (Zanotti and Cendron, 2014).
Considering the general non-invasive nature of H. pylori, it
is believed that secreted proteins play an important role in
the bacterial survival and ultimate disease development. The
potential role of some secreted proteins, such as Vacuolating
cytotoxin A (Vac A), Tumor necrosis factor alpha-inducing
protein (Tip-alpha), HP0175, HP0305, andNeutrophil-activating
protein (HP-NAP) has been suggested in various studies
(Suganuma et al., 2005; D’Elios et al., 2007; Palframan et al.,
2012; Pathak et al., 2013). However, there are still many other
hypothetical or less-studied secreted proteins of H. pylori whose
role in bacterial pathogenesis remains unidentified. With this in
view, this study was focused on functional characterization of the
protein HP1286.
Presence of HP1286 in the external medium of H. pylori
culture has been reported in several independent studies
(Bumann, 2002; Kim et al., 2002; Müller et al., 2013). Crystal
structure analysis led to the placement of HP1286 in the family
of YceI-like proteins, due to the presence of a cavity formed by
an eight-stranded β-barrel (Sisinni et al., 2010). However, based
on the structure and shape of the internal cavity, which varies
from other members of the family, it was suggested that HP1286
has the function of binding and/or transporting amphiphilic
molecules (Sisinni et al., 2010). Another study on the adaption
of H. pylori to acidic stress reported that HP1286 expression
is strongly up regulated in a UreI-negative strain, a mutant
unable to transport urea inside the cell (Toledo et al., 2002).
In addition, a recent study showed that recombinant HP1286
induces apoptosis in gastric epithelial cell line AGS (Li et al.,
2012). The balance between cell death and cell growth is essential
for the normal function of gastric mucosa. By induction of
apoptosis in gastric epithelial cells, HP1286 along with other
known apoptosis-inducing factors of H. pylori (Kuck et al., 2001;
Basak et al., 2005; Kim et al., 2007) could eventually damage the
gastric epithelial cell layer, allowing the interaction of HP1286
and other virulence factors with various immune cells in the
lamina propria.
In this study, we have studied the apoptosis-inducing ability
of HP1286 on other possible target cells such as macrophages,
monocytes, neutrophils, and T cells. We provide evidence
indicating that although rHP1286 interacts with several immune
cells, it is capable of inducing apoptosis in only macrophages.
Apoptosis inducing ability of a H. pylori mutant strain 26695,
lacking HP1286 expression, was significantly impaired. In
addition, we have identified the host cell signaling pathways that
regulate rHP1286-induced apoptosis in macrophages.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
H. pylori strains 26695 (ATCC 700392D-5), J99 (ATCC 700392),
TN2GF4, P12, CCUG17875, HPAG1, 67:21, and 67:20 has been
described previously (Björkholm et al., 2001; Basmarke-Wehelie
et al., 2011; Tavares and Pathak, 2015). The bacteria were grown
on Columbia blood agar plates (Acumedia) supplemented with
8% horse blood (Hatunalab) and 8% horse serum (Hatunalab)
at 37◦C under microaerophilic conditions. For growth in
liquid culture, cells were grown in Brucella broth (Acumedia)
containing 8% horse serum with shaking at 37◦C under
microaerophilic conditions. The Escherichia coli BL21 (DE3) and
DH5α strains were grown in Luria-Bertani Miller (LBM) media.
Cell Culture and Treatments
All cell lines were obtained from American Type Culture
Collection except HEK293-hTLR4A-MD2-CD14 (HEK-TLR4)
cells (InvivoGen). The murine macrophage cell line RAW264.7
(TIB-71) was cultured in DMEM (Gibco, Life Technologies)
supplemented with 10% heat-inactivated fetal bovine serum
(FBS) (Sigma-Aldrich). Human monocytic cell line THP-1 (TIB-
202), human T lymphocyte cell line Jurkat (TIB-152), and
human HL-60 promyelocytic leukemia cells were maintained
in RPMI-1640 (Gibco, Life Technologies) with 10% FBS at
37◦C and 5% CO2. THP-1 cells were differentiated into
macrophages in the presence of 100 nM phorbol 12-myristate
13-acetate (PMA) (Sigma-Aldrich) for 3 days. HL-60 cells
were treated with 1 mM Retinoic acid (RA) (Sigma-Aldrich)
for 7 days to differentiate into neutrophil-like cells. HEK-
TLR4 cells were cultured in DMEM with 10% FBS, 50 U/ml
penicillin, 50 µg/ml streptomycin, 2 mM l-glutamine, 10 µg/ml
Blasticidin (InvivoGen), and 50 µg/ml HygroGold (InvivoGen).
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As indicated, cells were treated either with various concentrations
of rHP1286 or the same volume of protein storage buffer. As a
positive control, E. coli LPS (500 ng/ml; Sigma-Aldrich) was used.
In some experiments, cells were pretreated with vehicle alone or
U0126 or ZVAD-FMK (Calbiochem, Merck4biosciences) for 30–
60 min. The neutralizing TNF antibody (10 µg/ml, clone MP6-
XT22;MAB4101) was obtained fromR&D Systems. For infection
studies, wild-typeH. pylori strain 26695 (Wt) or hp1286-deficient
mutant strain (∆hp1286) was added to macrophages at MOI100.
For the preparation of H. pylori conditioned medium (CM), Wt
and ∆hp1286 strains were grown in DMEM supplemented with
10% FBS and 0.5% yeast extract for 20 h. CM was filtered with a
0.22 µm filter and added to RAW264.7 cells at 1:4 ratio.
In vitro Differentiation of MDMs
MDM were generated as described previously (Pathak et al.,
2013). Briefly, RosetteSep human monocyte enrichment cocktail
(Stem Cell Technologies) was used to isolate CD14-positive
monocytes from buffy coats (obtained from the blood bank at
Karolinska University Hospital, Huddinge) by negative selection.
Isolated cells were stained with anti-CD14 antibody (Clone
TUK4; DAKO) to determine the purity. Monocytes were allowed
to adhere on cell culture plates for 2 h followed by washing of
unbound cells. Monocytes were cultured for 6–7 days in RPMI
1640 medium supplemented with 10% FBS and recombinant
humanmacrophage colony-stimulating factor (M-CSF; 50 ng/ml;
Immunotools). To assess the differentiation of monocytes into
macrophages, changes in cell morphology were monitored by
light microscopy (Carl Zeiss, Axiovert 40 C) and cells were
stained with anti-CD68 (clone Y1/82A; BD biosciences) and
anti-CD14 antibodies. Sample acquisition was performed using
LSRFortessa flow cytometer (BD Biosciences).
Generation of H. pylori 266951hp1286
Mutant Strain
Genomic DNA from H. pylori 26695 was isolated using
a Genomic DNA isolation kit (Promega) following the
manufacturer’s instructions. hp1286-specific primers A (5′-
TCTAAAAAGTCTAGCGCTCCGGGAA-3′), B (5′-CCA
ACTTACTGATTTAAACGCCAAACTAACACCAA-3′), C
(5′- AATAAGTGATAATAAGGAGATGAGGTAAAGATT
GAG-3′), D (5′-AGAGGACTTCAAATCACTCAAAAAGAAT
TGC-3′), were used to amplify the up- and downstream regions,
respectively. The Chloramphenicol resistance gene (CAT) was
amplified by PCR from pACY184 vector using primer pair Cat
1(5′- GTTAGTTTGGCGTTTAAATCAGTAAGTTGGCAGC
AT-3′) and Cat 2 (5′- CTCAATCTTTACCTCTTATTATCACTT
ATTCAGGCG -3′). PCR products were purified using the Gel
purification kit (OMEGA bio-tek). The primers were designed
with overlapping homologies at the end. PCR reaction was
performed using three PCR products for five cycles without any
primers followed by 30 cycles with primers A and D. The purified
PCR product was mixed with H. pylori strain 26695 to allow
natural transformation using the method of spot transformation.
150 ng of purified PCR product was mixed with 100 µl of
bacteria (1 × 108 bacteria/ml stock) and spotted onto blood
agar plates. After 6 h, the transformation spot was spread over
the plate and incubated for further 24 h. The bacteria were then
moved onto selective blood agar plates containing 15–20 µg/ml
of Chloramphenicol and incubated for 3 to 7 days. Positive
clones were identified by PCR. Absence of HP1286 expression
in the mutant strain was confirmed by western blot using an
antibody raised against rHP1286.
Cloning, Expression, and Purification of
HP1286
The construct for expression of sequence encoding amino
acids 18 to 182 of HP1286 was generated by cloning of the
PCR product at NdeI and XhoI sites of the vector pET28b+
(Novagen). The genomic DNA from H. pylori 26695 was
used as template in the PCR reaction. Primers used were:
5′-GCGAGCTCATATGAAACCTTATACGATTG-3′ (Forward)
and 5′-AAACTCGAGTTGGGCGTAAGCTTCTA-3′ (Reverse).
Induction of the protein was carried in E. coli BL21 (DE3) at 37◦C
for 3–4 h with the addition of isopropyl thio-β-d-galactoside
(100µM) in Luria-Bertani (LB) media. Hexa-His-tagged HP1286
was purified from the soluble fraction by chromatography
on Talon resin (Clontech). To remove imidazole, the purified
protein was dialyzed overnight followed by another purification
step using an endotoxin removal column (Pierce). Amount of
endotoxin in the purified protein was assessed by an endotoxin
detection kit (Pierce) and the purified protein was concentrated
using Amicon Ultra-4 centrifugal filter (Millipore). After staining
with the Coomasie brilliant blue dye, the proteins appeared as
a single band under reducing conditions. For the generation of
an irrelevant-His-tagged (Irr-His) protein, anotherH. pylori gene
(HP1563) was cloned in the same vector pET28b+ at Nde1 and
XhoI sites. Irr-His was overexpressed in E. coli BL21 (DE3) and
purified from the soluble fraction. The purified protein was of
expected size (24 kDa).
Protein Extraction from H. pylori and
Immunoblotting
The methods for cell lysate preparation and immunoblotting
were described previously (Tavares and Pathak, 2015). A 10 µl
sample of cell lysate or 30 µl of filtered culture supernatant
from each strain were used for immunoblotting. Protein
A affinity-purified polyclonal antibody against rHP1286 was
generated by EZbiolab (USA). AhpC antibody has been described
previously (Tavares and Pathak, 2015). The band intensities of the
immunoblots were quantified using the ImageJ software (NIH,
Bethesda, MA, USA).
Binding Assay for rHP1286 Using FACS
and Immunoblotting
Cells were treated with rHP1286 (1 µg/ml) for 15 min. Unbound
protein was removed by washing with PBS. Cells were further
incubated with an anti-His-tag antibody (Thermo fisher) (1:1,000
dilution) in FACS buffer (2% BSA in PBS) for 1 h on ice.
After incubation, cells were washed twice with FACS buffer
and stained with an Alexa 488-conjugated anti-mouse IgG
antibody (Molecular Probes) (1:5,000 dilution) for 30 min on ice,
followed by washing with FACS buffer. Binding of HP1286 was
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analyzed by flow cytometry using an LSRFortessa flow cytometer.
FlowJo software (Tree Star, USA) was used for the data analysis.
Cell lysates from untreated or rHP1286-treated samples were
immunoblotted with anti-His tag antibody. Anti-actin antibody
(Thermo Scientific) (1:5,000 dilution) was used to confirm equal
loading.
Binding Assay for rHP1286 by
Immunofluorescence
RAW 264.7 cells were grown in 8-well chamber slides (Nunc) to
∼50% confluence. The cells were treated with rHP1286 (1µg/ml)
for 15 min. Unbound protein was removed by washing with PBS.
Cells were fixed in 2% formaldehyde for 10–15 min at room
temperature, washed with PBS and were incubated in blocking
buffer (2% BSA, 0.1% Tween20 in PBS) for 60 min at room
temperature, followed by staining with anti-His-tag antibody
(Thermo fisher) (1:500 dilution), for 1 h at room temperature.
After washing with blocking buffer, cells were stained with
Alexa Fluor 488-labeled secondary antibody (Molecular Probes)
(1:5,000 dilution) for 1 h at room temperature. Slides were
mounted with ProLong R© Gold mounting medium with DAPI
(4′, 6′-diamidino-2-phenylidole) (Molecular Probes). Images
were captured with a fluorescent microscope (Axiovision Cell
Observer HS, Carl Zeiss).
Measurement of Apoptosis
Measurement of apoptosis was performed as described
previously (Pathak et al., 2013). Briefly, 1 × 105 cells were
stained with Annexin V-FITC antibody and Propidium Iodide
(BD Biosciences) for 15 min in Annexin binding buffer (10 mM
HEPES pH 7.4, 140 mM NaCl and 2.5 mM CaCl2) following
manufacturer’s instructions. Stained cells were analyzed by
flow cytometry. Cells positive for Annexin V and/or PI were
determined. FlowJo software (Tree Star, USA) was used for the
data analysis.
Activation Assay for Caspase 3/7
Caspase-3 activity was measured using the Caspase 3/7 activity
assay kit (AAT Bioquest, Inc., USA) following the manufacturer’s
instructions. Briefly, 5 x 104 cells were challenged with rHP1286
(1 µg/ml) or E. coli LPS (500 ng/ml) for 24 h followed by
the addition of 100 µl/well of caspase 3 assay solution. The
fluorescence intensity wasmeasured (Ex/Em= 350/450 nm) after
1 h incubation. POLARstar Omega Instrument (BMG Labtech)
was used for the data acquisition.
ELISA for TNF and IL8
The amount of TNF or IL8 in the conditioned medium was
measured using commercially available ELISA kit (Immunotools)
following the manufacturer’s instructions.
Growth Curve and Viability of H. pylori
26695 Wt and 266951hp1286 Mutant Strain
The growth of H. pylori 26695 Wt and 266951hp1286 mutant
strain in Brucella broth medium containing 8% serum was
followed for 48 h by measuring the OD600 at specific time points.
The initial optical density of each bacterial strain was adjusted
to 0.05 in the referred media. H. pylori 266951hp1286 mutant
was grown in the presence of 20 µg/ml of Chloramphenicol.
To determine the viability, samples of each bacterial culture
were collected at the time points of 8, 24, and 48 h,
serially diluted, plated on blood agar dishes to determine
the colonies forming units (CFU). Number for colonies were
counted after 4–5 days of incubation under microaerophilic
conditions.
Preparation of Mammalian Cell Lysates
and Immunoblotting
The method used for cell lysate preparation and immunoblotting
were described previously (Pathak et al., 2013). Briefly,
cell lysates were prepared by the addition of SDS-PAGE
sample reducing buffer to cells after washing twice with PBS,
followed by heating at 95◦C for 10 min. Immunoblotting
was performed using anti-phospho ERK1/2 (D13.14.4E)
(1:1,000 dilution), anti-phospho-p38 (D3F9), anti-phospho-
JNK (81E11), and anti-ERK1/2 (137F5) (1:1,000 dilution)
antibodies from Cell Signaling Technology. Anti-phospho-c-Fos
(Thr325) antibody was from Bioss antibodies. An anti-actin
antibody (Thermo Scientific) (1:5,000 dilution) was used to
confirm equal loading. The secondary antibodies included
goat anti-rabbit IgG and goat anti-mouse IgG conjugated to
IRdye800CW (Li-COR) (1:10,000 dilution). Band intensities
were quantified using the ImageJ software, and actin was
used to normalize the total amount of protein loaded in
each well.
Cytoplasmic and Nuclear Extract
Preparation
Extracts were prepared using a Cytoplasmic and Nuclear
Extraction kit (Nordic BioSite) following the manufacturer’s
instructions. Briefly, cells were washed with ice cold PBS
and the pellet was resuspended into the volume equal to
seven times of cytoplasmic extraction reagent. After 30 min
incubation on ice, the lysate was centrifuged at 16000 x g
for 10 min at 4◦C. Supernatant (cytoplasmic fraction) was
carefully removed and the pellet was resuspended into the
volume equal to two times of the nuclear extraction buffer.
Lysates were placed on ice for 30 min with occasional vortexing
followed by centrifugation at 16000 x g for 10 min at 4◦C.
Supernatant (nuclear fraction) was collected. Immunoblotting
was performed using anti-phospho ERK1/2, anti-ERK1/2, anti-
Histone H3 (Biolegend) and anti-α-Tubulin (B-5-1-2, Sigma)
antibodies.
Statistical Analysis
All experiments were performed at least three times, eachwith≤3
samples. Statistical analysis was performed using the GraphPad
Prism 6.0 software. The differences between multiple groups
were analyzed using one-way ANOVA. Student’s t-test and non-
parametric Man-Whitney test was used to analyze difference
between two groups. Values of p < 0.05 were considered
statistically significant.
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RESULTS
Expression and Release of HP1286 by
H. pylori
HP1286 is highly conserved among H. pylori strains. The level of
HP1286 expression among H. pylori strains was tested using an
antibody raised against rHP1286. Although HP1286 expression
was observed in all strains, the level of expression varied
significantly among some strains (Figure 1A). The expression of
the protein in the strain TN2GF4 was significantly lower than
all other strains. The same lysates were blotted with antibodies
against AhpC, a highly abundant protein of H. pylori. No
difference in the level of AhpC expression was observed among
the tested strains (Figure 1A). The presence of a signal peptide
(1–17 aa) at the N-terminus, suggested the secretory nature of
HP1286 and the release of protein in the external medium has
been reported in previous studies with H. pylori strains NCTC
11637 and ATCC43504 (Kim et al., 2002; Toledo et al., 2002).
We further assessed the level of protein HP1286 released in the
culture medium of several other H. pylori strains. As observed
FIGURE 1 | Expression and release of HP1286 in different H. pylori strains. Whole cell lysates (A) and cell culture supernatant (B) from equal number of cells of
different H. pylori strains were immunoblotted with anti-HP1286 antibody. The blot was reprobed with anti-AhpC antibody. Data shown is the representative of six
independent experiments. The bar diagram indicates the band intensities normalized to the loading control (A) and the mean ± SD of band intensities (B). Statistically
significant differences were observed between TN2GF4 and other strains in both whole cell lysate (A) and culture supernatant (B), which is indicated by *(p < 0.05).
The strain HPAG1 showed statistically significant difference from all strains except TN2GF4 in the culture supernatant (B), which is indicated by **(p < 0.05)
(C) rHP1286 was separated on 4–15% SDS-polyacrylamide gel under reducing conditions followed by staining with Coomassie blue.
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in the cell culture lysate, there were significant differences in the
level of released protein among strains (Figure 1B). Interestingly,
for the strain HPAG1 the level of released protein did not
correlate with the expression level in the cell culture lysates.
As shown in Figures 1A,B, although the level of expression of
HP1286 in HPAG1 lysate was higher or similar to all other strains
except TN2GF4, the released level of HP1286 protein in the
external medium of the strain HPAG1 was significantly lower
than all strains except TN2GF4.
In order to study the effect of HP1286 on host cells, a sequence
encoding amino acids 18 to 182 of HP1286 from H. pylori strain
26695 was cloned, overexpressed and purified as aHis-tag protein
from the soluble fraction of E. coli. N-terminal amino acids 1–
17 were the predicted signal peptide. Hence, it was excluded
from the HP1286 construct. The recombinant purified HP1286
(rHP1286) had the expected size (Figure 1C).
rHP1286 Binds to Macrophages
Considering the release of HP1286 in the culture supernatant
of different strains of H. pylori, we further accessed the
binding of rHP1286 to macrophages. Binding of rHP1286 was
studied using several methods. Macrophages were incubated
with various concentrations of rHP1286, followed by washing
of unbound protein and staining with anti-His-tag antibody
and Alexa 488-conjugated secondary antibody. FACS analysis
indicated the binding of rHP1286 to human monocytic cell
line THP-1 (41.6 ± 6.7%) differentiated into macrophages
like cells by PMA treatment, RAW264.7 (58.02 ± 3.02%) and
human monocyte-derived macrophages (MDM) (51.6 ± 4.4%)
(Figures 2A,B). An irrelevant His-tagged protein was used to
rule out the possibility of the His-tag contributing to the binding
of purified protein to cells. Binding of the irr-His to macrophages
was not detected under similar conditions (Figure 2A). The
interaction of rHP1286 with macrophages was also detected by
immunoblotting of rHP1286-treated cell lysates with anti-His-
tag antibody (Figure 2C). Immunofluorescence staining further
confirmed the binding of rHP1286 to macrophages (Figure 2D).
Taken together, these results indicated that rHP1286 interacts
with macrophages.
rHP1286 Induces Apoptosis in
Macrophages
Considering the binding of rHP1286 to macrophages, we were
further interested in studying the host cell responses in rHP1286-
challenged macrophages. We observed morphological changes
associated with apoptosis in rHP1286-challenged macrophages.
To confirm an increase in apoptosis, RAW264.7 cells were treated
with various concentrations of rHP1286 for 8–32 h followed by
staining with Annexin V-FITC and PI. A representative FACS
analysis of apoptosis is shown in Figure 3A. Apoptosis was
induced in a dose- and time-dependent manner (Figures 3B,C).
In addition to RAW264.7 cells, rHP1286 also induced apoptosis
in PMA treated-THP-1 cells (Figure 3D), andMDM (Figure 3E).
Activation of caspases is an important indicator of apoptotic
cell death. Significantly higher caspase 3/7 activity was observed
in rHP1286-challenged RAW264.7 cells (Figure 3F). Taken
together, these results indicated that rHP1286 induces apoptosis
in macrophages.
Various control experiments were performed to confirm the
specific effect of rHP1286 on macrophages. An irrelevant His-
tag protein was used in parallel to rule out the possibility of
the His-tag contributing to the observed effects. Under similar
conditions, Irr-His failed to induce apoptosis in macrophages
(Figure 4A). LPS antagonist PMB had no effect on the apoptosis-
inducing ability of rHP1286 (Figure 4A). Furthermore, rHP1286
was incubated at 95◦C for 10 min before treatment of the
macrophages. The heat treatment resulted in the loss of
apoptosis-inducing ability, indicating that the effect is due
to the HP1286 protein (Figure 4A). In addition to these
controls, experiments were also performed using HEK cells,
which are naturally devoid of receptors for LPS signaling,
as well as HEK-TLR4 cells that were stably transfected with
LPS signaling receptors TLR4/MD2/CD14. rHP1286 failed to
induce IL8 in HEK-TLR4 cells at concentrations used in this
study (Figure 4B). As expected, our positive control E. coli LPS
induced a significantly higher amount of IL8 in HEK-TLR4 cells
(Figure 4B). Collectively, these results ruled out the possibility of
LPS contamination in rHP1286.
An isogenic mutant strain H. pylori 26695 was constructed to
confirm the apoptosis-inducing ability of endogenous HP1286,
The hp1286 gene was disrupted by insertion of a chloramphenicol
cassette and lack of HP1286 protein expression was verified
by immunoblotting with an antibody-raised against rHP1286
(Figure 4C). First, we questioned whether the protein could
have an effect on bacterial growth and/or viability. Growth
and viability of H. pylori 26695 Wt and 266951hp1286
was monitored up to 48 h. No significant differences in
growth were seen between the Wt and the mutant strain
(Figure 4D), which ruled out the possibility of the involvement
of HP1286 in the bacterial growth. In comparison to the
26695 Wt strain, significantly reduced apoptosis was observed in
RAW264.7 and MDM infected with 266951hp1286 confirming
that the endogenous HP1286 regulates macrophage apoptosis
(Figure 4E). Furthermore, significantly less apoptosis was
observed in RAW264.7 cells incubated in culture supernatant
(CM) from 266951hp1286 (Figure 4F).
The Effect of HP1286 on Various Cell Types
It has been reported that rHP1286 induces apoptosis in
gastric epithelial cells (Li et al., 2012), and we observed
apoptosis in HP1286-challenged macrophages. We further
studied the apoptosis-inducing ability of rHP1286 on other
possible target cells types such as monocytes, T cells, and
neutrophils. Under similar conditions, rHP1286 failed to
induce apoptosis in undifferentiated THP-1 cells (human
monocytic cell line) and human primary monocytes (Figure 5A).
HL-60 (human promyelocytic leukemia) cells were either
undifferentiated or differentiated to a neutrophil-like phenotype.
High level of background apoptosis was observed in the
retinoic acid-differentiated HL-60 cells, which is in agreement
with previous observations (Marshall et al., 2008; Sjölinder
et al., 2012). The rate of apoptosis was not affected in
rHP1286-challenged undifferentiated or differentiated HL-60
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FIGURE 2 | rHP1286 binds to macrophages. (A) Cells were incubated either with buffer (Ctrl) or with rHP1286 (1 µg/ml) or an irrelevant His-tagged protein (Irr-His,
1 µg/ml) for 15 min, followed by washing with PBS to remove unbound protein and subsequent staining with anti-His-tag antibody and Alexa Fluor 488 conjugated
secondary antibody. Binding was analyzed by flow cytometry. One representative data from results obtained in ≥3 independent experiments is shown. (B) The results
obtained in the binding assays are depicted as percentage binding of rHP1286 to cells in RAW264.7 (five experiments), THP-1 (+PMA) (three experiments) and MDM
(three donors). Values indicate mean ± SD. Statistically significant differences are indicated by *(p < 0.05). (C) RAW264.7 and THP-1 (+PMA) cells were incubated with
rHP1286 or Irr-His as described above followed by the preparation of cell lysates in SDS-PAGE sample buffer. Lysates were immunoblotted with anti-His-tag antibody
and the blots were reprobed with anti-actin antibody. One representative data from results obtained in ≥3 independent experiments is shown. (D) RAW264.7 cells
were incubated with rHP1286 as described above. Immunofluorescence analysis was performed after staining with anti-His-tag antibody and Alexa Fluor 488-labeled
secondary antibody. Cells were mounted in ProLong® Gold mounting medium with DAPI. Scale bar, 10 µm. One representative experiment of four is shown.
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FIGURE 3 | rHP1286 induces apoptosis in macrophages. (A) RAW 264.7 cells were incubated either with protein storage buffer (Ctrl) or rHP1286 (1 µg/ml) for
24 h. Cells were washed, stained with Annexin V-FITC antibody and PI as described in material and methods and analyzed by flow cytometry. Result shown is the
representative of results obtained in more than four independent experiments performed with at least duplicate samples. RAW264.7 cells were treated with various
concentrations of rHP1286 as indicated in figure legends or E. coli LPS (500 ng/ml) for 24 h (B) or treated with rHP1286 (1 µg/ml) for different time periods (C).
Apoptotic cells were analyzed by flow cytometry. Values indicate mean ± SD of four independent experiments. ns indicates statistically non-significant. PMA-treated
THP-1 (D) and MDM (E) cells were incubated either with rHP1286 (1 µg/ml) or E. coli LPS (500 ng/ml) for 24 h. Apoptotic cells were analyzed by flow cytometry after
staining with Annexin V-FITC and PI. Values in panel D indicates mean ± SD of five independent experiments. For MDM, values indicate mean ± SD of apoptosis in
three donors. (F) RAW264.7 cells were treated either with buffer (Ctrl) or rHP1286 (1 µg/ml) or E. coli LPS (500 ng/ml) for 24 h. Caspase 3/7 activity was measured.
Data shown is mean ± SD of four independent experiments performed in triplicates. Statistically significant differences are indicated by *(p < 0.05).
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FIGURE 4 | Apoptosis-inducing ability is a property specific to HP1286.
(A) RAW264.7 cells were treated for 24 h with buffer (Ctrl) or rHP1286 (1
µg/ml) or an irrelevant His-tagged protein (Irr-His, 1 µg/ml). In another set of
experiments, rHP1286 was treated with polymyxin B (PMB + rHP1286) for 1 h
or rHP1286 was subjected to boiling for 30 min (heat) before treatment of cells.
Apoptotic cells were analyzed by flow cytometry after staining with Annexin
V-FITC and PI. Values indicate mean ± SD of four independent experiments.
Statistically significant differences are indicated by *(p < 0.05). ns indicates
statistically non-significant. (B) TLR4-HEK cells were treated with rHP1286 (1
µg/ml) or E. coli LPS (500 ng/ml) for 16 h. IL-8 level in the cell culture
supernatant was determined by ELISA. Data shown is the mean ± SD of two
independent experiments. (C) Cell lysates from H. pylori 26695 wild-type strain
(Wt) or the mutant strain (1hp1286) were immunoblotted with anti-HP1286
antibody. Blots were reprobed with anti-AhpC antibody to confirm equal
loading. Data shown is representative of results obtained in three independent
experiments. (D) H. pylori 26695 Wt or 1hp1286 were grown in liquid culture
for 48 h and optical density was measured at indicated time points. Data
shown is the results obtained from three independent experiments. (E)
RAW264.7 and MDM cells were infected either with H. pylori 26695 Wt or
(Continued)
FIGURE 4 | Continued
1hp1286 at MOI100. Apoptotic cells were analyzed by flow cytometry. Data
shown is the results obtained from three independent experiments (RAW264.7)
or three donors (MDM). (F) RAW264.7 cells were incubated in the conditioned
medium (CM) of H. pylori 26695 Wt or 1hp1286 for 24 h. Apoptotic cells were
analyzed by flow cytometry. The error bars represent standard deviations.
Statistically significant differences are indicated by *(p < 0.05).
cells (Figure 5A). Similarly, rHP1286 did not induce significantly
higher apoptosis in Jurkat cells (human T lymphocyte cells),
whereas our positive control Camptothecin (CPT) did induce
apoptosis (Figure 5B). The binding of rHP1286 was observed
in undifferentiated THP-1 (69.5 ± 4.5%), Jurkat (93.1 ±
2.02%), and HL60 (86.7 ± 5.31%) (Figures 5C,D). Taken
together, these results indicated that although rHP1286 interacts
with various cells, it induces apoptosis in only certain
cell types.
rHP1286-Induced Macrophage Apoptosis
Is Independent of TNF
H. pylori induces TNF in macrophages and TNF has been shown
to regulate macrophage apoptosis (Rizwan et al., 2008; Alvi et al.,
2011; Pathak et al., 2013). We therefore studied the possibility
of TNF-dependent apoptosis induction in rHP1286-challenged
macrophages. Pretreatment of macrophages with anti-TNF
neutralizing antibody had no effect on rHP1286-induced
apoptosis, whereas LPS-induced apoptosis was significantly
blocked (Figure 6A). Furthermore, rHP1286 failed to induce
significantly higher level of TNF in the culture medium of
macrophages up to 16 h after treatment at the concentrations
that induced apoptosis in macrophages (Figure 6B). Significantly
higher level of TNF was detected in the culture supernatant of
LPS-treated macrophages (Figure 6B). Collectively, these results
indicated that HP1286-induced macrophage apoptosis does
not depend on TNF induction. In addition, rHP1286-induced
macrophage apoptosis was significantly inhibited by pan-caspase
inhibitor, suggesting that rHP1286 triggered caspase-dependent
macrophage apoptosis (Figure 6C).
rHP1286-Induced Macrophage Apoptosis
Is Dependent on ERK MAPK
ERK MAPK has been reported to regulate apoptosis in H. pylori
infected macrophages (Asim et al., 2010). We therefore, studied
the possible involvement of ERK MAPK in rHP1286-induced
macrophage apoptosis. Macrophages were pre-treated with
U0126 to block ERKMAPK followed by treatment with rHP1286.
Blocking of ERK MAPK resulted in significantly lower apoptosis
in rHP1286-treated RAW264.7 and MDM cells (Figure 7A).
Similar results were obtained in THP-1 (+PMA) cells (data not
shown). Further, to confirm the activation of ERK MAPK in
rHP1286-challenged macrophages, the level of phosphorylated
ERK 1/2 was assessed. rHP1286 was found to induce ERK
activation in a time-dependent manner in both cell types
(Figures 7B,C). The ERK activation kinetics differed slightly
between the two cell types. Significantly higher ERK MAPK
activation in MDM was observed as early as 15 min, whereas
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FIGURE 5 | The effect of rHP1286 on various cell types. (A) THP-1 (−PMA) cells, primary human monocytes and untreated (−RA) or retinoic acid treated (+RA)
HL60 cells were incubated with buffer (Ctrl) or rHP1286 (1 µg/ml) for 24 h. (B) Jurkat cells were treated for 24 h with buffer (Ctrl) or rHP1286 (1 µg/ml) or
Camptothecin (CPT, 10 µM). Cells were stained with Annexin V-FITC and PI and the percentage of apoptotic cells were analyzed by flow cytometry. Values indicate
mean ± SD of four independent experiments (THP-1, HL60 and Jurkat) and three donors (primary monocytes). Statistically significant differences are indicated by
*(p < 0.05). (C) Different cells as indicated in the figure legends were incubated either with protein storage buffer (Ctrl) or with rHP1286 (1 µg/ml) for 15 min. Cells were
washed, stained with anti-His-tag antibody and Alexa Fluor 488-conjugated secondary antibody followed by flow cytometry analysis. Result shown is the
representative of results obtained in ≥3 independent experiments performed with at least duplicate samples. (D) The results obtained in the binding assays are
depicted as percentage binding of rHP1286 to cells. Values indicate mean ± SD. Statistically significant differences are indicated by *(p < 0.05).
maximum ERK activation was observed for both cell types after
30 min of rHP1286 treatment. A densitometry analysis of ERK
phosphorylation kinetics from ≥3 independent experiments is
shown in Figures 7B,C.
It has been reported previously that ERK-dependent apoptosis
requires nuclear translocation of phosphorylated ERK (Asim
et al., 2010; Teixeiro and Daniels, 2010); therefore we further
studied the level of phosphorylated ERK in cytoplasmic
and nuclear fractions of macrophages. Phosphorylated-ERK
was detected in both cytoplasmic and nuclear fractions of
rHP1286-treated RAW264.7 cells (Figure 8A). Furthermore,
rHP1286 was found to induce phosphorylation of c-Fos
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FIGURE 6 | The role of TNF and caspases in rHP1286-induced macrophage apoptosis. (A) RAW264.7 cells were pretreated either with isotype control IgG or
TNF neutralizing antibody (10 µg/ml) for 1 h followed by treatment with either rHP1286 (1 µg/ml) or E. coli LPS (500 ng/ml) for 24 h. Cells were stained with Annexin
V-FITC and PI and the percentage of apoptotic cells were analyzed by flow cytometry. Values indicate mean ± SD of four independent experiments. (B) RAW264.7
cells were treated either with buffer (Ctrl) or rHP1286 (1 µg/ml) or E. coli LPS (500 ng/ml) for 16 h. The release of TNF in the cell culture supernatant was measured by
ELISA. The data shown is the mean ± SD of four independent experiments. (C) Percentage of apoptotic cells was determined in RAW264.7 cells treated either with
the vehicle control (DMSO) or pan-caspase inhibitor Z-VAD-FMK (20 µM) for 1 h followed by 24 h incubation with rHP1286 (1 µg/ml). The data shown is the mean ±
SD of four independent experiments. Statistically significant differences are indicated by *(p < 0.05).
at Thr325 in a time-dependent manner in RAW264.7 cells
(Figure 8B).
Depending on the stimulus used, MAPKs have been shown to
differentially regulate apoptosis in different cell types (Wada and
Penninger, 2004). Considering the binding of rHP1286 to other
cell types but absence of apoptosis induction, we were further
interested in identifying the differences in MAPK activation.
Under similar conditions, rHP1286 failed to activate ERK, p38
and JNKMAPKs in Jurkat cells (Figure 8C).
DISCUSSION
Macrophages play an essential role in the host responses against
H. pylori-derived factors and also from signals from epithelial
cells. In order to establish a persistent infection, H. pylori must
modulate the effector functions of the macrophages for their own
benefit and survival. Although H. pylori has been demonstrated
tomodulate themacrophage responses in various studies (Gobert
et al., 2002a; Chaturvedi et al., 2004; Asim et al., 2010), only
a small number of macrophage function-regulating H. pylori
virulence factors have been identified to date, such as HP0940,
HP0986, Urease, JHP0290 (Harris et al., 1998; Alvi et al., 2011;
Pathak et al., 2013; Tenguria et al., 2014). In this study, we
have identified HP1286 as a novel regulator of macrophage
apoptosis. The identification and characterization of unknown or
less-studied virulence factors is very important when considering
the fact that we still do not know fully how or which factors
actually determine the disease development in a small percentage
of infected individuals.
Sequence homology analysis amongH. pylori strains indicated
that HP1286 is highly conserved (Li et al., 2012). We observed
significant differences in the level of expression of the protein
among some H. pylori strains. Furthermore, the amount
of released protein in the culture supernatant also varied
significantly among some strains. These differences could be an
intrinsic property of the isolate or may be due to the differences
in the encountered environmental conditions at the sites of
origin of the isolates, such as pH, nutrients, level of mucins, etc.
H. pylori shows high genetic diversity and it is believed that the
final disease development at least partially depends on strain-
specific features. In several independent studies, differences in
the level of expression or release of H. pylori proteins have been
observed (Hennig et al., 2004; Suganuma et al., 2005; Devi et al.,
2014; Tavares and Pathak, 2015). These differences in the level of
expression or release could potentially determine the virulence of
different strains. Further studies are required to understand the
mechanisms that regulate the expression and release of HP1286
and the precise relationship between expression level and the
virulence of the bacterial strains.
H. pylori infection induces a chronic (lymphocytic) and active
(neutrophilic) inflammatory responses. Although H. pylori is
generally considered as a non-invasive pathogen, it can disrupt
the gastric epithelial cell layer, and the presence of bacterial
proteins in the lamina propria has been reported (Mai et al.,
1992; Semino-Mora et al., 2003). In a majority of gastritis and
gastric cancer cases, H. pylori was found to be in direct contact
with immune cells (Moese et al., 2007). A series of studies
observed the responses of monocytes, neutrophils, macrophages,
T-cells, and B-cells to H. pylori and bacterium derived-products
(Boncristiano et al., 2003; Sundrud et al., 2004; Bussiere et al.,
2006; D’Elios et al., 2007; Schmees et al., 2007; Asim et al.,
2010). Studies have also shown that contact with live bacteria
is not required and responses were observed when immune
cells were separated by a filter or treated with H. pylori water
extract or whole cell lysate (Gobert et al., 2002a,b; Chaturvedi
et al., 2004). HP1286 was reported to induce apoptosis in gastric
epithelial cell line AGS (Li et al., 2012). Considering the effect of
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FIGURE 7 | The role of ERK MAPK in rHP1286-induced macrophage apoptosis. (A) RAW264.7 and MDM cells were pretreated either with vehicle control
(DMSO) or U0126 (10 µM) for 30 min followed by treatment with rHP1286 (1 µg/ml). Apoptotic cells were analyzed by flow cytometry. The data shown is the mean ±
SD of three independent experiments (RAW264.7) or three donors (MDM). Statistically significant differences are indicated by *(p < 0.05). RAW264.7 cells (B) or MDM
(C) were treated with rHP1286 (1 µg/ml) for indicated time periods. As a positive control for ERK activation, RAW264.7 cells were treated with E. coli LPS for 30 min.
Western blotting was performed with anti-phospho-ERK antibody. Blots were reprobed with anti-ERK and anti-actin antibody to ensure equal loading. Data shown is
the representative of four independent experiments (RAW264.7) and three donors (MDM). The bar diagram indicates band intensities in western blots normalized to
the actin control. *(p < 0.05) indicates statistically significant differences.
HP1286 and other known epithelial cell layer disrupting factors
we further studied the possible interaction of HP1286 with other
target cell types. rHP1286 was found to interact with various cell
types such as macrophages, monocytes, neutrophils and T-cells,
indicating that the protein is recognized by certain receptor(s),
which is/are present on multiple cell types. In comparison to
macrophages, better binding of rHP1286 was observed in other
cell types. Considering the differences in the degree of binding
of the rHP1286 among cell types under similar experimental
conditions, it is expected that the level of the receptor expression
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FIGURE 8 | The effect of rHP1286 on MAPKs and c-Fos activation in
different cell types. (A) Cytopalsmic and nuclear fraction of rHP1286-treated
cells were immunoblotted with anti-phospho-ERK antibody. Blots were
reprobed with anti-ERK or Histone H3 antibody to conform equal loading.
Cytoplasmic and nuclear fractions were immunoblotted with α-Tubulin
antibody to check purity. Data shown is the representative of four independent
experiments. (B) RAW264.7 cells were treated with rHP1286 (1 µg/ml) for
indicated time periods. Cell lysates were immunoblotted with
anti-phosho-c-Fos (Thr325) antibody and reprobed with anti-actin antibody to
confirm equal loading. Data shown is the representative of four independent
experiments. (C) Jurkat cells were treated with rHP1286 (1 µg/ml) for
indicated time periods. Cell lysates were immunoblotted with
anti-phospho-ERK, anti-phospho-p38 and anti-phospho-JNK antibodies. As a
positive control, Jurkat cells were infected with H. pylori 26695 (HP) for 60
min. Blots were reprobed with anti-actin antibody to confirm equal loading.
Data shown is the representative of three independent experiments.
possibly vary among different cell-types. Currently, we are
working on the identification of the host cell surface receptor that
recognizes rHP1286.
Exposure to rHP1286 resulted in a dose- and time-dependent
apoptosis in macrophages. However, the same protein failed
to induce apoptosis in primary monocytes, T cells and
neutrophil-like HL 60 cells under similar conditions. These
observations suggest that although rHP1286 interacts with
several cell types, it might have effects that are specific to each
cell type. This is not an unexpected phenomenon especially when
considering the pathogenesis of a highly successful pathogen
such as H. pylori. Recently, we reported that another H. pylori
secreted protein JHP0290 was able to bind to both macrophages
and gastric epithelial cells. However, this interaction resulted
in pro-apoptotic signaling in macrophages, whereas binding to
gastric epithelial cells resulted in proliferative and anti-apoptotic
signaling pathways (Pathak et al., 2013; Tavares and Pathak,
2015). Differences in the activation of the host cell pro-apoptotic
and anti-apoptotic signaling pathways in different cell types
could be the possible reason behind the observed differences.
DifferentMAPKs have been shown to regulate apoptosis in Jurkat
cells (Kutuk et al., 2005; Pestka et al., 2005). rHP1286 failed
to induce activation of any MAPK under the conditions tested,
which could explain the reason behind absence of apoptosis
in Jurkat cells. Currently, we are working on understanding
the response of other cell types to HP1286 and the differences
in the signaling pathways that are involved in the regulation
of apoptosis. It was interesting to note the similarities and
differences between HP1286 and JHP0290 (Li et al., 2012; Pathak
et al., 2013; Tavares and Pathak, 2015). Studies have been initiated
to identify the factors that regulate the similarities and differences
between the host cell responses to JHP0290 and HP1286. Several
strategies were adopted to confirm that the observed effect was
not due to endotoxin contamination in the purified protein.
Firstly, the purified protein was incubated with an endotoxin
removal column to remove any LPS in the purified HP1286
and studies were performed using HEK293 cells (naturally
lack receptors for endotoxin signaling) and HEK293-TLR4 cells
(stably transfected with receptors for LPS signaling). rHP1286
was able to bind to both cell types, but failed to induce IL-8, thus
confirming the endotoxin-independent effects. This conclusion
was further supported by the observation that rHP1286 failed
to induce significantly higher level of TNF in RAW264.7 cells
and a mutant strain of H. pylori lacking HP1286 expression
was significantly impaired in its ability to induce macrophage
apoptosis.
Upon H. pylori challenge, macrophages produce TNF, a
cytokine that is involved in pro- apoptotic signaling (Harris
et al., 2000; Aggarwal, 2003; Pathak et al., 2013). We previously
reported that anotherH. pylori secreted protein JHP0290 induces
macrophage apoptosis via TNF-dependent and -independent
pathways (Pathak et al., 2013). However, HP1286 appears to
induce macrophage apoptosis via TNF-independent pathways
since neutralizing antibodies against TNF had no effect on
rHP1286-induced macrophage apoptosis. This view was further
strengthened by the observation that rHP1286 failed to induce
TNF in macrophages under the conditions, which induced
macrophage apoptosis. ERK MAPK has been shown to regulate
H. pylori-induced macrophage apoptosis (Asim et al., 2010).
However, specific H. pylori virulence factor (s) that regulate
macrophage apoptosis via ERK MAPK have not been identified
so far. We recently identified H. pylori secreted protein JHP0290
as one of the regulators of ERK-dependent macrophage apoptosis
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(Pathak et al., 2013). In this study we identified another regulator
of macrophage apoptosis inH. pylori. To our knowledge, HP1286
is only the second characterized virulence factor of H. pylori that
induces macrophage apoptosis via ERK MAPK.
Sequence similarities suggest that HP1286 belongs to the
YceI-like family of proteins (Sisinni et al., 2010). YceI-like
family proteins have been suggested to play an important role
in isoprenoid quinone metabolism or in transport or storage
(Handa et al., 2005). However, 3D structure of the protein
HP1286 revealed distinct properties from other members of the
family including an inner cavity structural adaption for a new
binding specificity and it was suggested that the physiological
function of HP1286 might differ from other members of this
family (Sisinni et al., 2010). It was also observed that under
acidic stress, HP1286 was one of the limited numbers of proteins,
which was overexpressed by a mutant strain of H. pylori (Ure1-
negative) that was unable to incorporate urea (Toledo et al.,
2002). This upregulation could be a bacterial strategy for survival
in the hostile environment via either regulation of bacterial
growth/survival or by affecting the responses of target host
cells. Other reports have provided some information on the
functional role of HP0243 (neutrophil-activating protein) and
HP0485 (catalase-like enzyme), two other proteins that were
found to be upregulated in Ure1-negative strain (Tomb et al.,
1997; Tonello et al., 1999; Zanotti et al., 2002). Here, we have
provided evidences that suggest the function of HP1286 during
bacterial pathogenesis via regulation of macrophage apoptosis.
In addition to regulations of host cell responses, HP1286 could
also be involved in bacterial growth/survival since the structural
features indicated that the function of the protein could be
sequestering of fatty acids or amides in the environment of the
bacterium, which may protect the external membrane from their
surfactant properties and/or to affect bacterial metabolism by
regulating the supply of necessary fatty acids (Sisinni et al., 2010).
However, we did not observe any difference in the bacterial
growth or viability in Wt and HP1286 protein deficient strains
ofH. pylori 26695. Further studies are required to understand the
role of HP1286 in bacterial growth or survival, if any.
During persistent H. pylori infection, the number of
macrophage gradually declines, which is likely to occur via
induction of apoptosis (Asim et al., 2010). This decline is
expected to protect the bacteria from the microbicidal activities
of macrophages, which in turn will help in persistence.
Therefore, by virtue of its ability to induce macrophage
apoptosis, HP1286 could possibly play an important role in the
bacterial persistence and may also influence subsequent disease
development.
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